文献
J-GLOBAL ID:201802282950042620
整理番号:18A1779060
進化する2型糖尿病景観におけるグリクラジドMRの場所:他のスルホニル尿素および新規経口抗高血糖薬との比較【JST・京大機械翻訳】
The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents
著者 (6件):
Colagiuri Stephen
(Boden Institute of Obesity, Nutrition and Exercise, University of Sydney, Sydney, NSW, Australia)
,
Matthews David
(Oxford Centre for Diabetes, Endocrinology and Metabolism, and Harris Manchester College, University of Oxford, Oxford, UK)
,
Leiter Lawrence A.
(Division of Endocrinology & Metabolism, Li Ka Shing Knowledge Institute of St. Michael’s Hospital, University of Toronto, Ontario, Canada)
,
Chan Siew Pheng
(Department of Medicine, University of Malaya Medical Centre, Kuala Lumpur 50603, W.P., Malaysia)
,
Sesti Giorgio
(Department of Medical and Surgical Science, University Magna-Graecia of Catanzaro, 88100 Catanzaro, Italy)
,
Marre Michel
(Diabetes Department, Hopital Bichat-Claude Bernard, Assistance Publique des Hopitaux de Paris, Universite Denis Diderot Paris 7, and INSERM U1138, Paris, France)
資料名:
Diabetes Research and Clinical Practice
(Diabetes Research and Clinical Practice)
巻:
143
ページ:
1-14
発行年:
2018年
JST資料番号:
W3208A
ISSN:
0168-8227
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
オランダ (NLD)
言語:
英語 (EN)